Published in Mol Psychiatry on April 03, 2012
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 5.99
Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell (2015) 1.61
Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. Annu Rev Med (2013) 1.36
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function. Neuron (2013) 1.25
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23
PLD3 in non-familial Alzheimer's disease. Nature (2015) 1.18
Coding mutations in SORL1 and Alzheimer disease. Ann Neurol (2015) 1.09
The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med (2015) 1.09
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08
Cholesterol: its regulation and role in central nervous system disorders. Cholesterol (2012) 1.08
Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci. Ann Neurol (2015) 1.05
Genetics of Alzheimer's disease. Neurotherapeutics (2014) 1.02
Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations. Hum Mol Genet (2014) 1.02
Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J Neurosci (2012) 1.02
EVA: Exome Variation Analyzer, an efficient and versatile tool for filtering strategies in medical genomics. BMC Bioinformatics (2012) 0.92
Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population. Oncotarget (2015) 0.91
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan. Mol Psychiatry (2013) 0.90
SorLA complement-type repeat domains protect the amyloid precursor protein against processing. J Biol Chem (2014) 0.89
Application of next-generation sequencing technologies in Neurology. Ann Transl Med (2014) 0.88
Cholesterol metabolism and homeostasis in the brain. Protein Cell (2015) 0.86
De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease. Mol Psychiatry (2015) 0.85
Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-β peptide. J Neurosci (2013) 0.84
Next-generation sequencing in understanding complex neurological disease. Expert Rev Neurother (2013) 0.84
Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations. J Alzheimers Dis (2013) 0.83
The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease. Future Neurol (2012) 0.83
Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun (2015) 0.82
ABCA7 rare variants and Alzheimer disease risk. Neurology (2016) 0.81
The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review. Mol Genet Genomics (2014) 0.81
Heterozygous Chorein Deficiency in Probable Tau-negative Early-onset Alzheimer Disease. Alzheimer Dis Assoc Disord (2016) 0.81
Identification of rare variants in Alzheimer's disease. Front Genet (2014) 0.80
Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease. Acta Neuropathol (2016) 0.80
α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction. Proc Natl Acad Sci U S A (2014) 0.79
Genetic loci associated with Alzheimer's disease. Future Neurol (2014) 0.79
SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity. J Clin Invest (2016) 0.79
Noradrenergic dysfunction in Alzheimer's disease. Front Neurosci (2015) 0.78
Maturational conversion of dendritic early endosomes and their roles in L1-mediated axon growth. J Neurosci (2014) 0.78
Alzheimer disease: modeling an Aβ-centered biological network. Mol Psychiatry (2016) 0.78
Genomics in neurological disorders. Genomics Proteomics Bioinformatics (2014) 0.78
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease. Acta Neuropathol (2016) 0.78
TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol Aging (2016) 0.78
Exome sequencing provides additional evidence for the involvement of ARHGAP29 in Mendelian orofacial clefting and extends the phenotypic spectrum to isolated cleft palate. Birth Defects Res A Clin Mol Teratol (2016) 0.77
SNX27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein. J Neurosci (2016) 0.76
Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease. Alzheimers Dement (2015) 0.75
SORL1 mutations in early- and late-onset Alzheimer disease. Neurol Genet (2016) 0.75
The presenilin 1 p.Gly206Ala mutation is a frequent cause of early-onset Alzheimer's disease in Hispanics in Florida. Am J Neurodegener Dis (2016) 0.75
Sorting receptor SORLA: cellular mechanisms and implications for disease. Cell Mol Life Sci (2016) 0.75
IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking. J Neuroinflammation (2017) 0.75
Multidisciplinary approach to genomics research in Africa: the AfriCRAN model. Pan Afr Med J (2015) 0.75
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med (2017) 0.75
Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease. PLoS One (2016) 0.75
Sortilin Fragments Deposit at Senile Plaques in Human Cerebrum. Front Neuroanat (2017) 0.75
Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet (2017) 0.75
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother (1985) 7.83
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology (2003) 6.51
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer (2007) 5.38
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ (2010) 3.37
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A (1995) 2.70
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol (1999) 2.65
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet (1993) 2.40
Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet (1990) 2.38
Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. JAMA (1998) 2.37
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother (1987) 2.35
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18
Neuropsychological outcome after a first symptomatic ischaemic stroke with 'good recovery'. Eur J Neurol (2011) 2.13
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
FORRepeats: detects repeats on entire chromosomes and between genomes. Bioinformatics (2003) 2.07
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06
Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res (2000) 2.06
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04
Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology (2006) 2.00
Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet (1999) 1.95
Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care (2001) 1.88
Timely detection of meningococcal meningitis epidemics in Africa. Lancet (2001) 1.88
Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet (1994) 1.85
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J Med Genet (2005) 1.78
Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr (1998) 1.74
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Usefulness of transcranial color-coded sonography in the diagnosis of cerebral vasospasm. Stroke (1999) 1.67
Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J Med Genet (2005) 1.65
Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke (1994) 1.65
Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64
Body mass index and incidence of dementia: the PAQUID study. Neurology (2003) 1.63
Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet (2005) 1.60
Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations. J Urol (2006) 1.59
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58
Prediction of pathology in primary progressive language and speech disorders. Neurology (2009) 1.57
Pediatric cerebral aneurysms. J Neurosurg (2001) 1.57
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Giant cervical epidural veins after lumbar puncture in a case of intracranial hypotension. AJNR Am J Neuroradiol (2000) 1.55
Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet (1995) 1.55
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol (1998) 1.53
Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet (1998) 1.53
Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation (2004) 1.52
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52
[Management of a new influenza A/H1N1 virus pandemic within the hospital: statement of the German Society of Pneumology]. Pneumologie (2009) 1.51
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C study. Neurology (2011) 1.50